Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
about
Allergen injection immunotherapy for seasonal allergic rhinitisAllergen-specific immunotherapy in pediatric allergic asthmaSublingual Immunotherapy: A Useful Tool for the Allergist in Private PracticeManagement and Prevention of AnaphylaxisSubcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?Safety of engineered allergen-specific immunotherapy vaccinesRecommendations for appropriate sublingual immunotherapy clinical trialsAntigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.Therapeutic interventions in severe asthmaAnaphylaxis in the allergy practice.Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementInternational consensus on (ICON) pediatric asthmaUpdate on allergy immunotherapySublingual immunotherapy: World Allergy Organization position paper 2013 update.Changes in Peak Flow value during immunotherapy administrationSublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews.Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in ChildrenPatients on subcutaneous allergen immunotherapy are at risk of intramuscular injections.Skin prick testing in patients using beta-blockers: a retrospective analysis.Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence.Extracts from The Cochrane Library: Sublingual immunotherapy for allergic rhinitis.An EAACI "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)": the methodologyClinical practice guideline: Allergic rhinitis.Clinical contraindications to allergen immunotherapy: an EAACI position paper.The safety of self-administered allergen immunotherapy during the buildup and maintenance phasesGuideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoBasophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E.Limits on risks for healthy volunteers in biomedical research.T regulatory cells in allergen-specific immunotherapy.Molecular approaches for new vaccines against allergy.Immediate-type allergy to drugs and related compounds: evaluation and management.The efficacy assessment of a self-administered immunotherapy protocolAllergen specific immunotherapy induced multi-organ failure.A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.Practice patterns of allergen immunotherapy in Korea: where are we?A 5-year study of systemic reactions using both shared and patient-specific vaccinesHow safe are the biologicals in treating asthma and rhinitis?A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia).Endonasal phototherapy with Rhinolight for the treatment of allergic rhinitis.
P2860
Q24243115-0C90AAC9-FEDF-412E-B7FF-B5998F966012Q26739254-3DD06B83-2BE8-4503-8E12-84F4831BAA8DQ26747200-BCC47164-E5A5-4207-AA9F-46690AB7A7C7Q26766190-C8193DD6-8FEC-472D-9690-E891040148BDQ26852119-C9634800-2C97-428E-ADFF-93246704FF76Q26860962-E0B5520B-B064-4B45-8FCA-55857D3AE862Q27011713-20D70B76-37E2-4D10-BC4E-DC5C20DB1293Q27687250-9C51D9EA-A242-469C-93D9-88633334B53FQ28079238-1E9C4FDE-F123-45E9-B853-54835DE2A76AQ30208850-4400F3FE-9722-4E0F-B14D-70BA07051D6BQ30371972-59F3E81C-0F70-4ED0-9CAF-50218566D52CQ30393965-C9864FFA-A115-4D14-A498-BC41F7798D0CQ30436062-B84EC57B-D5F9-4C4B-8D73-CEF47FD54E59Q30440195-842F2466-BDB5-4063-AFB5-998081BE36F0Q30468626-627D9114-7D58-4DBA-AC2E-4CABC1FBE037Q31030974-9850863D-66D9-488E-AE72-6081D4572915Q33378244-FDDA4532-1D7F-49E2-AA5A-BE3C9439826BQ33586188-A4E25AE3-E1C3-4C20-9FA3-C005889B6723Q33595034-F57AEE28-F3BC-4ABD-82CE-AF24B88B60BAQ33657325-4B4FC130-B533-40EF-A61F-88837F4DBDDBQ33802263-BE8D32A8-572C-4CA5-85B1-23754AC9AB7AQ33873154-33CD1E63-DAC8-4617-B037-8645409C740EQ33962778-431132BA-AE0E-42DA-84FB-BBB91EFB2208Q34460983-6177AB53-0A4D-484B-8E68-BDC786D1CE4CQ34669524-89CC7955-D2EE-43F0-9A4B-82015C2215C3Q35733569-B86DBAB9-18A3-4DC5-97A3-888FC9E43D75Q35777126-F0C772B5-835C-4DE8-ADEE-3F8FE350D82CQ36099160-F5E80ECD-CAC2-425B-9910-DAD6681F1AF1Q36238424-9555DF43-89FD-406E-BF82-02177676B737Q36327399-DDE93FD2-1337-4C1B-919C-DE5322595718Q36383819-3E524D34-200B-464F-9B40-06C6E094C1EFQ36406780-7C9461A9-7AD3-47BD-B3EA-80BFB92DA408Q36881918-1A9B3676-D30F-4DFC-85F5-0000A8F546B9Q36931611-74613945-23F2-4E81-A4CD-BFB4C4413F44Q36945591-CCBE457A-163A-477E-BB3A-A8EDC1C1F27EQ37129280-F94FF20A-C3C5-48DD-A4CD-A41CFB32B700Q37221456-A0227B0E-9EB0-4814-AE16-D10632710AE7Q37479670-618D5FF8-6C1F-435F-868F-B927CEDAA45CQ37652965-E7FA6D84-AD66-4B5A-A412-BD1B37259028Q37658811-E3B0B646-E153-4BCB-97B2-5EBBB5268176
P2860
Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
@en
type
label
Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
@en
prefLabel
Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
@en
P2093
P1476
Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
@en
P2093
David I Bernstein
Gary M Liss
Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology
Mark Wanner
P304
P356
10.1016/J.JACI.2004.02.006
P407
P577
2004-06-01T00:00:00Z